name,category,terms2'-5'-oligoadenylate synthetase 2, 69/71kDa,INTERPRO[450002588$IPR002934:Nucleotidyltransferase, 450005548$IPR006116:2-5-oligoadenylate synthetase, ubiquitin-like region, 450005549$IPR006117:2-5-oligoadenylate synthetase, conserved site, 450017222$IPR018952:2'-5'-oligoadenylate synthetase 1, domain 2/C-terminal]
2'-5'-oligoadenylate synthetase 2, 69/71kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000881$lipoprotein, 790000959$microsome, 790000969$mitochondrion, 790001004$myristate, 790001063$nucleotide-binding, 790001064$nucleotidyltransferase, 790001065$nucleus, 790001304$repeat, 790001339$rna-binding, 790001547$transferase]
2'-5'-oligoadenylate synthetase 2, 69/71kDa,UP_SEQ_FEATURE[850001029$chain:2'-5'-oligoadenylate synthetase 2, 850102588$compositionally biased region:Pro-rich (linker), 850105869$lipid moiety-binding region:N-myristoyl glycine, 850106258$modified residue, 850106259$mutagenesis site, 850113824$region of interest:OAS domain 1, 850113825$region of interest:OAS domain 2, 850117294$sequence conflict, 850118574$splice variant]
5-hydroxytryptamine (serotonin) receptor 1D,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000431$IPR000505:5-Hydroxytryptamine 1D receptor, 450001978$IPR002231:5-Hydroxytryptamine receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
5-hydroxytryptamine (serotonin) receptor 1D,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
5-hydroxytryptamine (serotonin) receptor 1D,PIR_SUPERFAMILY[630005396$PIRSF005474:5-hydroxytryptamine receptor 1, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
5-hydroxytryptamine (serotonin) receptor 1D,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001026$neurotransmitter receptor, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
5-hydroxytryptamine (serotonin) receptor 1D,UP_SEQ_FEATURE[850002194$chain:5-hydroxytryptamine receptor 1D, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2,INTERPRO[450001187$IPR001345:Phosphoglycerate/bisphosphoglycerate mutase, 450002719$IPR003094:Fructose-2,6-bisphosphatase, 450011723$IPR013078:Phosphoglycerate mutase, 450011724$IPR013079:6-phosphofructo-2-kinase, 450014584$IPR016260:Bifunctional 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphate 2-phosphatase]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2,KEGG_PATHWAY[470038729$hsa00051:Fructose and mannose metabolism]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2,PIR_SUPERFAMILY[630000821$PIRSF000709:6PFK_2-Ptase, 630000822$PIRSF000709:bifunctional 6-phosphofructo-2-kinase/fructose-2,6-bisphosphate 2-phosphatase]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000743$hydrolase, 790000825$kinase, 790000993$multifunctional enzyme, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001547$transferase]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2,UP_SEQ_FEATURE[850000131$active site:Proton donor, 850000158$active site:Tele-phosphohistidine intermediate, 850000362$binding site:Fructose-6-phosphate, 850002499$chain:6-phosphofructo-2-kinase/fructose-2,6- biphosphatase 2, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850110612$region of interest:6-phosphofructo-2-kinase, 850111707$region of interest:Fructose-2,6-bisphosphatase, 850117294$sequence conflict, 850118574$splice variant]
A kinase (PRKA) anchor protein 11,INTERPRO[450007659$IPR008382:A-kinase anchor 110 kDa]
A kinase (PRKA) anchor protein 11,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001162$phosphoprotein, 790001212$polymorphism]
A kinase (PRKA) anchor protein 11,UP_SEQ_FEATURE[850002960$chain:A-kinase anchor protein 11, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850114057$region of interest:PKA-RII subunit binding domain, 850117294$sequence conflict, 850117295$sequence variant]
A kinase (PRKA) anchor protein 3,INTERPRO[450007659$IPR008382:A-kinase anchor 110 kDa, 450016576$IPR018292:A-kinase anchor 110 kDa, C-terminal, 450016733$IPR018459:RII binding domain]
A kinase (PRKA) anchor protein 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001212$polymorphism]
A kinase (PRKA) anchor protein 3,UP_SEQ_FEATURE[850002965$chain:A-kinase anchor protein 3, 850106258$modified residue, 850106259$mutagenesis site, 850114057$region of interest:PKA-RII subunit binding domain, 850117294$sequence conflict, 850117295$sequence variant]
A kinase (PRKA) anchor protein 7,INTERPRO[450017747$IPR019510:Protein kinase A anchor protein, nuclear localisation signal domain, 450017748$IPR019511:Protein kinase A anchor protein, RI-RII subunit-binding domain]
A kinase (PRKA) anchor protein 7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000881$lipoprotein, 790000919$membrane, 790001004$myristate, 790001100$palmitate, 790001212$polymorphism]
A kinase (PRKA) anchor protein 7,UP_SEQ_FEATURE[850002970$chain:A-kinase anchor protein 7 isoform gamma, 850002971$chain:A-kinase anchor protein 7 isoforms alpha and beta, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850114237$region of interest:Required for apical membrane localization, 850114425$region of interest:Required for membrane localization, 850114538$region of interest:RII-binding, 850117295$sequence variant, 850118574$splice variant]
ABI family, member 3,INTERPRO[450001294$IPR001452:Src homology-3 domain, 450011527$IPR012849:Abl-interactor, homeo-domain homologous region]
ABI family, member 3,SMART[760000295$SM00326:SH3]
ABI family, member 3,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain]
ABI family, member 3,UP_SEQ_FEATURE[850003171$chain:ABI gene family member 3, 850102586$compositionally biased region:Pro-rich, 850105350$domain:SH3, 850117295$sequence variant]
ADAM metallopeptidase domain 21 pseudogene; ADAM metallopeptidase domain 21,INTERPRO[450001412$IPR001590:Peptidase M12B, ADAM/reprolysin, 450001561$IPR001762:Blood coagulation inhibitor, Disintegrin, 450001611$IPR001818:Peptidase M10A and M12B, matrixin and adamalysin, 450002537$IPR002870:Peptidase M12B, propeptide, 450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450006006$IPR006586:ADAM, cysteine-rich, 450011699$IPR013032:EGF-like region, conserved site, 450016643$IPR018358:Disintegrin, conserved site]
ADAM metallopeptidase domain 21 pseudogene; ADAM metallopeptidase domain 21,PIR_SUPERFAMILY[630006703$PIRSF006749:mouse meltrin alpha]
ADAM metallopeptidase domain 21 pseudogene; ADAM metallopeptidase domain 21,SMART[760000042$SM00050:DISIN, 760000538$SM00608:ACR]
ADAM metallopeptidase domain 21 pseudogene; ADAM metallopeptidase domain 21,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790000937$metal-binding, 790000941$metalloprotease, 790001252$Protease, 790001405$signal, 790001555$transmembrane, 790001648$zinc, 790001652$zymogen]
ADAM metallopeptidase domain 21 pseudogene; ADAM metallopeptidase domain 21,UP_SEQ_FEATURE[850015303$chain:Disintegrin and metalloproteinase domain- containing protein 21, 850102480$compositionally biased region:Cys-rich, 850102585$compositionally biased region:Poly-Val, 850102883$disulfide bond, 850103526$domain:Disintegrin, 850103596$domain:EGF-like, 850104962$domain:Peptidase M12B, 850105770$glycosylation site:N-linked (GlcNAc...), 850106244$metal ion-binding site:Zinc; catalytic, 850106245$metal ion-binding site:Zinc; in inhibited form, 850117294$sequence conflict, 850117368$short sequence motif:Cysteine switch, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ADAMTS-like 4,INTERPRO[450000771$IPR000884:Thrombospondin, type 1 repeat, 450009363$IPR010294:ADAM-TS Spacer 1, 450009938$IPR010909:PLAC]
ADAMTS-like 4,OMIM_DISEASE[520001646$Ectopia lentis, isolated, autosomal recessive]
ADAMTS-like 4,SMART[760000182$SM00209:TSP1]
ADAMTS-like 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000616$glycoprotein, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal]
ADAMTS-like 4,UP_SEQ_FEATURE[850003827$chain:ADAMTS-like protein 4, 850102586$compositionally biased region:Pro-rich, 850105021$domain:PLAC, 850105555$domain:TSP type-1 1, 850105566$domain:TSP type-1 2, 850105575$domain:TSP type-1 3, 850105576$domain:TSP type-1 4, 850105577$domain:TSP type-1 5, 850105578$domain:TSP type-1 6, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
ADP-ribosylation factor 1,BIOCARTA[30000022$h_arapPathway:ADP-Ribosylation Factor, 30000242$h_ptdinsPathway:Phosphoinositides and their downstream targets.]
ADP-ribosylation factor 1,INTERPRO[450004692$IPR005225:Small GTP-binding protein, 450006098$IPR006688:ADP-ribosylation factor, 450006099$IPR006689:ARF/SAR superfamily]
ADP-ribosylation factor 1,KEGG_PATHWAY[470038896$hsa05110:Vibrio cholerae infection]
ADP-ribosylation factor 1,PIR_SUPERFAMILY[630001857$PIRSF001711:ADP-ribosylation factor]
ADP-ribosylation factor 1,SMART[760000151$SM00177:ARF]
ADP-ribosylation factor 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000189$blocked amino end, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000510$er-golgi transport, 790000624$golgi apparatus, 790000639$gtp-binding, 790000881$lipoprotein, 790001004$myristate, 790001005$myristylation, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001162$phosphoprotein, 790001266$protein transport, 790001558$transport]
ADP-ribosylation factor 1,UP_SEQ_FEATURE[850004004$chain:ADP-ribosylation factor 1, 850105852$helix, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850118575$strand, 850118624$turn]
ADP-ribosylation factor-like 2,INTERPRO[450004692$IPR005225:Small GTP-binding protein, 450006098$IPR006688:ADP-ribosylation factor, 450006099$IPR006689:ARF/SAR superfamily]
ADP-ribosylation factor-like 2,PIR_SUPERFAMILY[630001857$PIRSF001711:ADP-ribosylation factor]
ADP-ribosylation factor-like 2,SMART[760000151$SM00177:ARF]
ADP-ribosylation factor-like 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000189$blocked amino end, 790000258$cell cycle, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000639$gtp-binding, 790000811$isopeptide bond, 790000881$lipoprotein, 790001004$myristate, 790001005$myristylation, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
ADP-ribosylation factor-like 2,UP_SEQ_FEATURE[850000387$binding site:GTP; via amide nitrogen, 850004038$chain:ADP-ribosylation factor-like protein 2, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850105852$helix, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850106258$modified residue, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP, 850117295$sequence variant, 850118575$strand]
AE binding protein 2,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450014303$IPR015880:Zinc finger, C2H2-like]
AE binding protein 2,SMART[760000323$SM00355:ZnF_C2H2]
AE binding protein 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
AE binding protein 2,UP_SEQ_FEATURE[850101971$chain:Zinc finger protein aebp2, 850102507$compositionally biased region:Glu-rich, 850102517$compositionally biased region:Gly-rich, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850112760$region of interest:Interaction with RBBP4, 850112890$region of interest:Interaction with SUZ12, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118709$zinc finger region:C2H2-type 2; degenerate, 850118711$zinc finger region:C2H2-type 3]
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast),INTERPRO[450003522$IPR004000:Actin/actin-like, 450003523$IPR004001:Actin, conserved site]
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast),PIR_SUPERFAMILY[630002457$PIRSF002337:Actin]
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast),SMART[760000240$SM00268:ACTIN]
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast),SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000950$methylated amino acid, 790000957$microfilament, 790000973$mitosis, 790001063$nucleotide-binding]
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast),UP_SEQ_FEATURE[850004743$chain:Alpha-centractin, 850106258$modified residue]
AT hook, DNA binding motif, containing 1,INTERPRO[450016267$IPR017956:AT hook, DNA-binding, conserved site]
AT hook, DNA binding motif, containing 1,SMART[760000336$SM00384:AT_hook]
AT hook, DNA binding motif, containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
AT hook, DNA binding motif, containing 1,UP_SEQ_FEATURE[850002980$chain:A.T hook DNA-binding motif-containing protein 1, 850102517$compositionally biased region:Gly-rich, 850102586$compositionally biased region:Pro-rich, 850102885$DNA-binding region:A.T hook 1, 850102888$DNA-binding region:A.T hook 2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
ATG2 autophagy related 2 homolog B (S. cerevisiae),COG_ONTOLOGY[90000079$Intracellular trafficking and secretion]
ATG2 autophagy related 2 homolog B (S. cerevisiae),INTERPRO[450013854$IPR015412:ATG2, C-terminal]
ATG2 autophagy related 2 homolog B (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
ATG2 autophagy related 2 homolog B (S. cerevisiae),UP_SEQ_FEATURE[850006877$chain:Autophagy-related protein 2 homolog B, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
ATH1, acid trehalase-like 1 (yeast),INTERPRO[450004658$IPR005195:Glycoside hydrolase family 65, central catalytic, 450011039$IPR012341:Six-hairpin glycosidase]
ATH1, acid trehalase-like 1 (yeast),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000617$glycosidase, 790000743$hydrolase]
ATH1, acid trehalase-like 1 (yeast),UP_SEQ_FEATURE[850003437$chain:Acid trehalase-like protein 1, 850102581$compositionally biased region:Poly-Ser, 850117294$sequence conflict, 850118574$splice variant]
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d,INTERPRO[450007946$IPR008689:ATPase, F0 complex, subunit D, mitochondrial]
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038891$hsa05010:Alzheimer's disease, 470038892$hsa05012:Parkinson's disease, 470038894$hsa05016:Huntington's disease]
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d,PIR_SUPERFAMILY[630005438$PIRSF005514:ATPase_F0_D_mt, 630005439$PIRSF005514:F-type ATP synthase, subunit d, mitochondrial]
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000281$cf(0), 790000356$complete proteome, 790000445$direct protein sequencing, 790000739$Hydrogen ion transport, 790000798$ion transport, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001558$transport]
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d,UP_SEQ_FEATURE[850006509$chain:ATP synthase subunit d, mitochondrial, 850106258$modified residue, 850118574$splice variant]
ATP-grasp domain containing 1,INTERPRO[450003342$IPR003806:ATP-grasp fold, DUF201-type, 450004935$IPR005479:Carbamoyl phosphate synthetase, large subunit, ATP-binding, 450010588$IPR011761:ATP-grasp fold]
ATP-grasp domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000906$manganese, 790000937$metal-binding, 790001063$nucleotide-binding, 790001212$polymorphism]
ATP-grasp domain containing 1,UP_SEQ_FEATURE[850006752$chain:ATP-grasp domain-containing protein 1, 850103068$domain:ATP-grasp, 850106174$metal ion-binding site:Manganese 1, 850106177$metal ion-binding site:Manganese 2, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ATP/GTP binding protein-like 2,INTERPRO[450000726$IPR000834:Peptidase M14, carboxypeptidase A]
ATP/GTP binding protein-like 2,SMART[760000546$SM00631:Zn_pept]
ATP/GTP binding protein-like 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000242$carboxypeptidase, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790001212$polymorphism, 790001252$Protease, 790001648$zinc]
ATP/GTP binding protein-like 2,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850014082$chain:Cytosolic carboxypeptidase 2, 850106218$metal ion-binding site:Zinc, 850117295$sequence variant, 850118574$splice variant]
ATPase family, AAA domain containing 1,INTERPRO[450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450003483$IPR003960:ATPase, AAA-type, conserved site]
ATPase family, AAA domain containing 1,SMART[760000335$SM00382:AAA]
ATPase family, AAA domain containing 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000811$isopeptide bond, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
ATPase family, AAA domain containing 1,UP_SEQ_FEATURE[850006779$chain:ATPase family AAA domain-containing protein 1, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ATPase family, AAA domain containing 3C,INTERPRO[450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450003483$IPR003960:ATPase, AAA-type, conserved site]
ATPase family, AAA domain containing 3C,SMART[760000335$SM00382:AAA]
ATPase family, AAA domain containing 3C,SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790001063$nucleotide-binding]
ATPase family, AAA domain containing 3C,UP_SEQ_FEATURE[850006789$chain:ATPase family AAA domain-containing protein 3C, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP]
ATPase, Ca++ transporting, plasma membrane 1,INTERPRO[450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450003534$IPR004014:ATPase, P-type cation-transporter, N-terminal, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005504$IPR006068:ATPase, P-type cation-transporter, C-terminal, 450005830$IPR006408:ATPase, P-type, calcium-transporting, PMCA-type, 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase, Ca++ transporting, plasma membrane 1,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway]
ATPase, Ca++ transporting, plasma membrane 1,PIR_SUPERFAMILY[630001445$PIRSF001297:Na(+)/K(+)-transporting ATPase alpha chain]
ATPase, Ca++ transporting, plasma membrane 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000211$calcium, 790000215$calcium transport, 790000218$calmodulin-binding, 790000264$cell membrane, 790000356$complete proteome, 790000743$hydrolase, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
ATPase, Ca++ transporting, plasma membrane 1,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850039438$chain:Plasma membrane calcium-transporting ATPase 1, 850102572$compositionally biased region:Poly-Glu, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850111170$region of interest:Calmodulin-binding subdomain A, 850111171$region of interest:Calmodulin-binding subdomain B, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ATPase, Ca++ transporting, plasma membrane 4,INTERPRO[450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450003534$IPR004014:ATPase, P-type cation-transporter, N-terminal, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005504$IPR006068:ATPase, P-type cation-transporter, C-terminal, 450005830$IPR006408:ATPase, P-type, calcium-transporting, PMCA-type, 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase, Ca++ transporting, plasma membrane 4,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway]
ATPase, Ca++ transporting, plasma membrane 4,PIR_SUPERFAMILY[630001445$PIRSF001297:Na(+)/K(+)-transporting ATPase alpha chain]
ATPase, Ca++ transporting, plasma membrane 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000211$calcium, 790000215$calcium transport, 790000218$calmodulin-binding, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000743$hydrolase, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790000924$membrane protein, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001555$transmembrane, 790001558$transport]
ATPase, Ca++ transporting, plasma membrane 4,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850039441$chain:Plasma membrane calcium-transporting ATPase 4, 850102572$compositionally biased region:Poly-Glu, 850102577$compositionally biased region:Poly-Lys, 850105852$helix, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850111170$region of interest:Calmodulin-binding subdomain A, 850111171$region of interest:Calmodulin-binding subdomain B, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
ATPase, Ca++ transporting, type 2C, member 1,INTERPRO[450000595$IPR000695:ATPase, P-type, H+ transporting proton pump, 450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450003534$IPR004014:ATPase, P-type cation-transporter, N-terminal, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005504$IPR006068:ATPase, P-type cation-transporter, C-terminal, 450005835$IPR006413:ATPase, P-type, calcium-transporting, PMR1-type, 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase, Ca++ transporting, type 2C, member 1,OMIM_DISEASE[520000549$benign chronic pemphigus (Hailey-Hailey disease), 520002207$Hailey-Hailey disease]
ATPase, Ca++ transporting, type 2C, member 1,PIR_SUPERFAMILY[630001445$PIRSF001297:Na(+)/K(+)-transporting ATPase alpha chain]
ATPase, Ca++ transporting, type 2C, member 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000211$calcium, 790000215$calcium transport, 790000356$complete proteome, 790000446$disease mutation, 790000624$golgi apparatus, 790000743$hydrolase, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
ATPase, Ca++ transporting, type 2C, member 1,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850009067$chain:Calcium-transporting ATPase type 2C member 1, 850105918$metal ion-binding site:Calcium 2, 850105922$metal ion-binding site:Calcium 2; via carbonyl oxygen, 850106107$metal ion-binding site:Magnesium, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
ArfGAP with GTPase domain, ankyrin repeat and PH domain 5; ArfGAP with GTPase domain, ankyrin repeat and PH domain 9; ArfGAP with GTPase domain, ankyrin repeat and PH domain 10; centaurin, gamma-like family, member 11 pseudogene,INTERPRO[450001021$IPR001164:Arf GTPase activating protein, 450001635$IPR001849:Pleckstrin homology, 450001870$IPR002110:Ankyrin, 450010818$IPR011993:Pleckstrin homology-type]
ArfGAP with GTPase domain, ankyrin repeat and PH domain 5; ArfGAP with GTPase domain, ankyrin repeat and PH domain 9; ArfGAP with GTPase domain, ankyrin repeat and PH domain 10; centaurin, gamma-like family, member 11 pseudogene,SMART[760000093$SM00105:ArfGap, 760000205$SM00233:PH, 760000220$SM00248:ANK]
ArfGAP with GTPase domain, ankyrin repeat and PH domain 5; ArfGAP with GTPase domain, ankyrin repeat and PH domain 9; ArfGAP with GTPase domain, ankyrin repeat and PH domain 10; centaurin, gamma-like family, member 11 pseudogene,SP_PIR_KEYWORDS[790000086$ank repeat, 790000356$complete proteome, 790000640$GTPase activation, 790000937$metal-binding, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
ArfGAP with GTPase domain, ankyrin repeat and PH domain 5; ArfGAP with GTPase domain, ankyrin repeat and PH domain 9; ArfGAP with GTPase domain, ankyrin repeat and PH domain 10; centaurin, gamma-like family, member 11 pseudogene,UP_SEQ_FEATURE[850006012$chain:Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 10, 850006020$chain:Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 9, 850103059$domain:Arf-GAP, 850104979$domain:PH, 850110004$region of interest:2 X 23 AA tandem repeats of A-L-E-F-N- [LS]-S-A-N-P-E-A-S-T-I-F-Q-R-N-S-Q-T-D, 850115074$repeat:1, 850115273$repeat:2, 850115631$repeat:ANK, 850118762$zinc finger region:C4-type]
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3,INTERPRO[450001021$IPR001164:Arf GTPase activating protein, 450001635$IPR001849:Pleckstrin homology, 450001870$IPR002110:Ankyrin, 450010818$IPR011993:Pleckstrin homology-type]
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3,KEGG_PATHWAY[470038841$hsa04144:Endocytosis]
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3,SMART[760000093$SM00105:ArfGap, 760000205$SM00233:PH, 760000220$SM00248:ANK]
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790000640$GTPase activation, 790000937$metal-binding, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3,UP_SEQ_FEATURE[850006008$chain:Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3, 850103059$domain:Arf-GAP, 850104979$domain:PH, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850117294$sequence conflict, 850118574$splice variant, 850118762$zinc finger region:C4-type]
B-cell CLL/lymphoma 9,INTERPRO[450014104$IPR015668:B Cell Lymphoma 9]
B-cell CLL/lymphoma 9,SP_PIR_KEYWORDS[790000002$3d-structure, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene, 790001642$wnt signaling pathway]
B-cell CLL/lymphoma 9,UP_SEQ_FEATURE[850007049$chain:B-cell CLL/lymphoma 9 protein, 850102565$compositionally biased region:Poly-Ala, 850102580$compositionally biased region:Poly-Pro, 850102586$compositionally biased region:Pro-rich, 850105852$helix, 850106258$modified residue, 850111365$region of interest:CTNNB1-binding, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
B-cell CLL/lymphoma 9-like,INTERPRO[450014104$IPR015668:B Cell Lymphoma 9]
B-cell CLL/lymphoma 9-like,SP_PIR_KEYWORDS[790000012$acetylation, 790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
B-cell CLL/lymphoma 9-like,UP_SEQ_FEATURE[850007050$chain:B-cell CLL/lymphoma 9-like protein, 850102562$compositionally biased region:Met-rich, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850113605$region of interest:Necessary for interaction with CTNNB1, 850118574$splice variant]
BCL2-associated agonist of cell death,BBID[10000006$103.Ca2-calmodulin_PK_cascade, 10000042$159.14-3-3_Apoptosis, 10000068$46.P13K_PTEN, 10000089$69.Survival_signaling_BH3-Bad, 10000105$83.Growth_factors_Survival_factors_Mitogens, 10000108$86.Apoptosis_Nematode&_Vert]
BCL2-associated agonist of cell death,BIOCARTA[30000004$h_achPathway:Role of nicotinic acetylcholine receptors in the regulation of apoptosis, 30000014$h_aktPathway:AKT Signaling Pathway, 30000030$h_badPathway:Regulation of BAD phosphorylation, 30000060$h_ceramidePathway:Ceramide Signaling Pathway, 30000062$h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage, 30000127$h_gleevecpathway:Inhibition of Cellular Proliferation by Gleevec, 30000148$h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation, 30000156$h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation, 30000242$h_ptdinsPathway:Phosphoinositides and their downstream targets., 30000255$h_rasPathway:Ras Signaling Pathway, 30000292$h_tffPathway:Trefoil Factors Initiate  Mucosal Healing]
BCL2-associated agonist of cell death,INTERPRO[450000611$IPR000712:Apoptosis regulator Bcl-2, BH, 450017140$IPR018868:Pro-apoptotic Bcl-2 protein, BAD]
BCL2-associated agonist of cell death,KEGG_PATHWAY[470038828$hsa04012:ErbB signaling pathway, 470038843$hsa04210:Apoptosis, 470038852$hsa04370:VEGF signaling pathway, 470038853$hsa04510:Focal adhesion, 470038877$hsa04722:Neurotrophin signaling pathway, 470038882$hsa04910:Insulin signaling pathway, 470038891$hsa05010:Alzheimer's disease, 470038893$hsa05014:Amyotrophic lateral sclerosis (ALS), 470038899$hsa05200:Pathways in cancer, 470038900$hsa05210:Colorectal cancer, 470038902$hsa05212:Pancreatic cancer, 470038903$hsa05213:Endometrial cancer, 470038905$hsa05215:Prostate cancer, 470038908$hsa05218:Melanoma, 470038910$hsa05220:Chronic myeloid leukemia, 470038911$hsa05221:Acute myeloid leukemia, 470038913$hsa05223:Non-small cell lung cancer]
BCL2-associated agonist of cell death,SMART[760000305$SM00337:BCL]
BCL2-associated agonist of cell death,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790000969$mitochondrion, 790000971$mitochondrion outer membrane, 790001162$phosphoprotein, 790001212$polymorphism]
BCL2-associated agonist of cell death,UP_SEQ_FEATURE[850007430$chain:Bcl2 antagonist of cell death, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850117319$short sequence motif:BH3, 850118575$strand]
BRCA2 and CDKN1A interacting protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000258$cell cycle, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
BRCA2 and CDKN1A interacting protein,UP_SEQ_FEATURE[850008349$chain:BRCA2 and CDKN1A-interacting protein, 850106258$modified residue, 850112132$region of interest:Interaction with BRCA2, 850112169$region of interest:Interaction with CDKN1A, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae),COG_ONTOLOGY[90000121$Transcription / DNA replication, recombination, and repair]
BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae),INTERPRO[450000283$IPR000330:SNF2-related, 450000307$IPR000357:HEAT, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450010814$IPR011989:Armadillo-like helical, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae),SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae),SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000466$dna-binding, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat]
BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae),UP_SEQ_FEATURE[850063604$chain:TATA-binding protein-associated factor 172, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850116140$repeat:HEAT 1, 850116152$repeat:HEAT 2, 850116162$repeat:HEAT 3, 850116163$repeat:HEAT 4, 850116164$repeat:HEAT 5, 850116165$repeat:HEAT 6, 850116166$repeat:HEAT 7, 850116167$repeat:HEAT 8, 850117399$short sequence motif:DEGH box, 850117610$short sequence motif:Nuclear localization signal]
Bartter syndrome, infantile, with sensorineural deafness (Barttin),OMIM_DISEASE[520000533$Bartter syndrome, type 4]
Bartter syndrome, infantile, with sensorineural deafness (Barttin),SP_PIR_KEYWORDS[790000169$bartter syndrome, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
Bartter syndrome, infantile, with sensorineural deafness (Barttin),UP_SEQ_FEATURE[850007325$chain:Barttin, 850106259$mutagenesis site, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),INTERPRO[450008710$IPR009617:Adipose-regulatory protein, Seipin]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),OMIM_DISEASE[520002905$Lipodystrophy, congenital generalized, type 2, 520003610$Neuropathy, distal hereditary motor, type V, 520004483$Silver spastic paraplegia syndrome, 520004539$Spastic paraplegia 17 (autosomal dominant), 520004540$spastic paraplegia 17 (Silver syndrome), 520004549$Spastic paraplegia with amyotrophy of hands and feet (Silver syndrome), 520004595$Spinal muscular atrophy, distal, type V]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000362$congenital generalized lipodystrophy, 790000430$diabetes mellitus, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000675$hereditary spastic paraplegia, 790000919$membrane, 790001015$neurodegeneration, 790001555$transmembrane]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),UP_SEQ_FEATURE[850059230$chain:Seipin, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
C-type lectin domain family 17, member A,INTERPRO[450001149$IPR001304:C-type lectin, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
C-type lectin domain family 17, member A,SMART[760000026$SM00034:CLECT]
C-type lectin domain family 17, member A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000848$Lectin, 790000919$membrane, 790001555$transmembrane]
C-type lectin domain family 17, member A,UP_SEQ_FEATURE[850008692$chain:C-type lectin and transmembrane domain- containing protein FLJ45910, 850103184$domain:C-type lectin, 850118623$transmembrane region]
C-type lectin domain family 9, member A,INTERPRO[450001149$IPR001304:C-type lectin, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
C-type lectin domain family 9, member A,SMART[760000026$SM00034:CLECT]
C-type lectin domain family 9, member A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000848$Lectin, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001409$Signal-anchor, 790001555$transmembrane]
C-type lectin domain family 9, member A,UP_SEQ_FEATURE[850008740$chain:C-type lectin domain family 9 member A, 850102883$disulfide bond, 850103184$domain:C-type lectin, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
C1q and tumor necrosis factor related protein 1,INTERPRO[450000941$IPR001073:Complement C1q protein, 450007490$IPR008160:Collagen triple helix repeat, 450008180$IPR008983:Tumour necrosis factor-like]
C1q and tumor necrosis factor related protein 1,SMART[760000097$SM00110:C1Q]
C1q and tumor necrosis factor related protein 1,SP_PIR_KEYWORDS[790000345$collagen, 790000356$complete proteome, 790000616$glycoprotein, 790001363$Secreted, 790001405$signal]
C1q and tumor necrosis factor related protein 1,UP_SEQ_FEATURE[850012307$chain:Complement C1q tumor necrosis factor- related protein 1, 850103196$domain:C1q, 850103389$domain:Collagen-like, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide]
C2 calcium-dependent domain containing 3,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting]
C2 calcium-dependent domain containing 3,SMART[760000211$SM00239:C2]
C2 calcium-dependent domain containing 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
C2 calcium-dependent domain containing 3,UP_SEQ_FEATURE[850008791$chain:C2 domain-containing protein 3, 850103200$domain:C2 1, 850103201$domain:C2 2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
CCR4-NOT transcription complex, subunit 2,INTERPRO[450006648$IPR007282:NOT2/NOT3/NOT5]
CCR4-NOT transcription complex, subunit 2,KEGG_PATHWAY[470038814$hsa03018:RNA degradation]
CCR4-NOT transcription complex, subunit 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
CCR4-NOT transcription complex, subunit 2,UP_SEQ_FEATURE[850010112$chain:CCR4-NOT transcription complex subunit 2, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
CD209 molecule,INTERPRO[450001149$IPR001304:C-type lectin, 450002094$IPR002353:Type II antifreeze protein, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
CD209 molecule,OMIM_DISEASE[520001447$Dengue fever, protection against, 520002347$HIV type 1, susceptibility to, 520003456$Mycobacterium tuberculosis, susceptibility to]
CD209 molecule,SMART[760000026$SM00034:CLECT]
CD209 molecule,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000211$calcium, 790000256$cell adhesion, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000496$Endocytosis, 790000616$glycoprotein, 790000733$host-virus interaction, 790000763$immune response, 790000848$Lectin, 790000907$mannose-binding, 790000919$membrane, 790000937$metal-binding, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001363$Secreted, 790001409$Signal-anchor, 790001555$transmembrane]
CD209 molecule,UP_SEQ_FEATURE[850010134$chain:CD209 antigen, 850102883$disulfide bond, 850103184$domain:C-type lectin, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105909$metal ion-binding site:Calcium, 850105946$metal ion-binding site:Calcium; via carbonyl oxygen, 850106259$mutagenesis site, 850110682$region of interest:7 X approximate tandem repeats, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850117295$sequence variant, 850117444$short sequence motif:Endocytosis signal, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
CD22 molecule,INTERPRO[450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011788$IPR013151:Immunoglobulin, 450011799$IPR013162:CD80-like, immunoglobulin C2-set, 450012396$IPR013783:Immunoglobulin-like fold]
CD22 molecule,KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs), 470038867$hsa04640:Hematopoietic cell lineage, 470038870$hsa04662:B cell receptor signaling pathway]
CD22 molecule,SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG]
CD22 molecule,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000152$B-cell, 790000256$cell adhesion, 790000264$cell membrane, 790000356$complete proteome, 790000436$dimer, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000848$Lectin, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
CD22 molecule,UP_SEQ_FEATURE[850000550$binding site:Sialic acid, 850007061$chain:B-cell receptor CD22, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104389$domain:Ig-like C2-type 4, 850104400$domain:Ig-like C2-type 5, 850104402$domain:Ig-like C2-type 6, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117520$short sequence motif:ITIM motif 1, 850117521$short sequence motif:ITIM motif 2, 850117522$short sequence motif:ITIM motif 3, 850117523$short sequence motif:ITIM motif 4, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
CD247 molecule,BIOCARTA[30000072$h_CSKPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor, 30000075$h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation, 30000076$h_ctlPathway:CTL mediated immune response against target cells , 30000150$h_IL12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development, 30000151$h_il17Pathway:IL 17 Signaling Pathway, 30000205$h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells, 30000279$h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents, 30000284$h_tcapoptosisPathway:HIV Induced T Cell Apoptosis, 30000285$h_tcraPathway:Lck and Fyn tyrosine kinases in initiation of TCR Activation, 30000286$h_tcrmolecule:T Cell Receptor and CD3 Complex, 30000287$h_tcrPathway:T Cell Receptor Signaling Pathway, 30000288$h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules, 30000295$h_thelperPathway:T Helper Cell Surface Molecules, 30000299$h_tob1Pathway:Role of Tob in T-cell activation]
CD247 molecule,INTERPRO[450002734$IPR003110:Phosphorylated immunoreceptor signaling ITAM]
CD247 molecule,KEGG_PATHWAY[470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038869$hsa04660:T cell receptor signaling pathway]
CD247 molecule,OMIM_DISEASE[520002611$Immunodeficiency due to defect in CD3-zeta]
CD247 molecule,PIR_SUPERFAMILY[630021605$PIRSF028738:CD3, zeta type]
CD247 molecule,SMART[760000067$SM00077:ITAM]
CD247 molecule,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000733$host-virus interaction, 790000919$membrane, 790001162$phosphoprotein, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001481$T-cell receptor, 790001555$transmembrane, 790001556$transmembrane protein]
CD247 molecule,UP_SEQ_FEATURE[850063404$chain:T-cell surface glycoprotein CD3 zeta chain, 850102883$disulfide bond, 850104484$domain:ITAM 1, 850104485$domain:ITAM 2, 850104486$domain:ITAM 3, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
CDC42 effector protein (Rho GTPase binding) 2,INTERPRO[450000079$IPR000095:PAK-box/P21-Rho-binding, 450015687$IPR017363:Cdc42 effector protein 2]
CDC42 effector protein (Rho GTPase binding) 2,PIR_SUPERFAMILY[630029620$PIRSF038036:Cdc42_effector_p2]
CDC42 effector protein (Rho GTPase binding) 2,SMART[760000256$SM00285:PBD]
CDC42 effector protein (Rho GTPase binding) 2,SP_PIR_KEYWORDS[790000268$cell shape, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
CDC42 effector protein (Rho GTPase binding) 2,UP_SEQ_FEATURE[850010182$chain:Cdc42 effector protein 2, 850103411$domain:CRIB, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant]
CDC42 small effector 1,INTERPRO[450000079$IPR000095:PAK-box/P21-Rho-binding]
CDC42 small effector 1,SMART[760000256$SM00285:PBD]
CDC42 small effector 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000268$cell shape, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001136$phagocytosis]
CDC42 small effector 1,UP_SEQ_FEATURE[850010188$chain:CDC42 small effector protein 1, 850103411$domain:CRIB, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106259$mutagenesis site, 850113403$region of interest:Mediates phosphoinositide-binding, 850118574$splice variant]
COMM domain containing 5,INTERPRO[450008972$IPR009886:HCaRG, 450016234$IPR017920:COMM domain]
COMM domain containing 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790001065$nucleus, 790001212$polymorphism]
COMM domain containing 5,UP_SEQ_FEATURE[850012277$chain:COMM domain-containing protein 5, 850103407$domain:COMM, 850117294$sequence conflict, 850117295$sequence variant]
COMM domain containing 9,INTERPRO[450008972$IPR009886:HCaRG, 450016234$IPR017920:COMM domain]
COMM domain containing 9,SP_PIR_KEYWORDS[790000356$complete proteome]
COMM domain containing 9,UP_SEQ_FEATURE[850012281$chain:COMM domain-containing protein 9, 850103407$domain:COMM, 850117294$sequence conflict]
COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis),BIOCARTA[30000138$h_hifPathway:Hypoxia-Inducible Factor in the Cardiovascular System]
COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis),INTERPRO[450000475$IPR000555:Mov34/MPN/PAD-1]
COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis),PIR_SUPERFAMILY[630013144$PIRSF016373:hypothetical protein, Caenorhabditis elegans B0547.1 type]
COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis),SMART[760000204$SM00232:JAB_MPN]
COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis),SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790001065$nucleus, 790001252$Protease, 790001410$signalosome]
COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis),UP_SEQ_FEATURE[850012530$chain:COP9 signalosome complex subunit 5, 850104794$domain:MPN, 850106244$metal ion-binding site:Zinc; catalytic, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117527$short sequence motif:JAMM motif]
COX assembly mitochondrial protein homolog (S. cerevisiae),INTERPRO[450012488$IPR013892:Cytochrome c oxidase biogenesis protein Cmc1-like]
COX assembly mitochondrial protein homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000371$copper, 790000937$metal-binding, 790000969$mitochondrion]
COX assembly mitochondrial protein homolog (S. cerevisiae),UP_SEQ_FEATURE[850012660$chain:COX assembly mitochondrial protein homolog, 850106258$modified residue, 850117294$sequence conflict]
COX15 homolog, cytochrome c oxidase assembly protein (yeast),INTERPRO[450003320$IPR003780:Cytochrome oxidase assembly]
COX15 homolog, cytochrome c oxidase assembly protein (yeast),KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038802$hsa00860:Porphyrin and chlorophyll metabolism]
COX15 homolog, cytochrome c oxidase assembly protein (yeast),OMIM_DISEASE[520000810$Cardiomyopathy, hypertrophic, early-onset fatal, 520002807$Leigh syndrome due to cytochrome c oxidase deficiency]
COX15 homolog, cytochrome c oxidase assembly protein (yeast),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000919$membrane, 790000969$mitochondrion, 790001555$transmembrane]
COX15 homolog, cytochrome c oxidase assembly protein (yeast),UP_SEQ_FEATURE[850013512$chain:Cytochrome c oxidase assembly protein COX15 homolog, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
COX16 cytochrome c oxidase assembly homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790001550$transit peptide, 790001555$transmembrane]
COX16 cytochrome c oxidase assembly homolog (S. cerevisiae),UP_SEQ_FEATURE[850013513$chain:Cytochrome c oxidase assembly protein COX16 homolog, mitochondrial, 850118617$transit peptide:Mitochondrion, 850118623$transmembrane region]
CUB domain containing protein 2,INTERPRO[450000750$IPR000859:CUB]
CUB domain containing protein 2,SMART[760000034$SM00042:CUB]
CUB domain containing protein 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal]
CUB domain containing protein 2,UP_SEQ_FEATURE[850012807$chain:CUB domain-containing protein 2, 850102883$disulfide bond, 850103433$domain:CUB 1, 850103444$domain:CUB 2, 850103453$domain:CUB 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
CUG triplet repeat, RNA binding protein 1,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait, 450014322$IPR015903:Ribonucleoprotein, BRUNO-like]
CUG triplet repeat, RNA binding protein 1,SMART[760000328$SM00360:RRM]
CUG triplet repeat, RNA binding protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000988$mrna processing, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001339$rna-binding]
CUG triplet repeat, RNA binding protein 1,UP_SEQ_FEATURE[850012820$chain:CUG-BP- and ETR-3-like factor 1, 850102597$compositionally biased region:Ser-rich, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105214$domain:RRM 3, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850118574$splice variant, 850118575$strand, 850118624$turn]
D-2-hydroxyglutarate dehydrogenase,COG_ONTOLOGY[90000064$Energy production and conversion]
D-2-hydroxyglutarate dehydrogenase,INTERPRO[450003627$IPR004113:FAD-linked oxidase, C-terminal, 450005528$IPR006094:FAD linked oxidase, N-terminal, 450011734$IPR013090:Phospholipase A2, active site, 450014512$IPR016166:FAD-binding, type 2, 450014513$IPR016167:FAD-binding, type 2, subdomain 1]
D-2-hydroxyglutarate dehydrogenase,OMIM_DISEASE[520001308$D-2-hydroxyglutaric aciduria]
D-2-hydroxyglutarate dehydrogenase,PIR_SUPERFAMILY[630006095$PIRSF006165:glycolate oxidase chain GlcD]
D-2-hydroxyglutarate dehydrogenase,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000537$FAD, 790000559$Flavoprotein, 790000969$mitochondrion, 790001092$oxidoreductase, 790001212$polymorphism, 790001550$transit peptide]
D-2-hydroxyglutarate dehydrogenase,UP_SEQ_FEATURE[850014158$chain:D-2-hydroxyglutarate dehydrogenase, mitochondrial, 850103738$domain:FAD-binding PCMH-type, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 47,INTERPRO[450000537$IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450010405$IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012608$IPR014014:RNA helicase, DEAD-box type, Q motif, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 47,PIR_SUPERFAMILY[630026222$PIRSF034443:PIRSF034443]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 47,SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 47,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001339$rna-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 47,UP_SEQ_FEATURE[850041113$chain:Probable ATP-dependent RNA helicase DDX47, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117383$short sequence motif:DEAD box, 850117676$short sequence motif:Q motif, 850118575$strand]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,INTERPRO[450000537$IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450010405$IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012608$IPR014014:RNA helicase, DEAD-box type, Q motif, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,PIR_SUPERFAMILY[630026222$PIRSF034443:PIRSF034443]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001212$polymorphism, 790001339$rna-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,UP_SEQ_FEATURE[850041114$chain:Probable ATP-dependent RNA helicase DDX49, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117383$short sequence motif:DEAD box, 850117676$short sequence motif:Q motif]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 56,INTERPRO[450001461$IPR001650:DNA/RNA helicase, C-terminal, 450010405$IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012608$IPR014014:RNA helicase, DEAD-box type, Q motif, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 56,SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 56,SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001331$ribosome biogenesis, 790001339$rna-binding, 790001345$rrna processing]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 56,UP_SEQ_FEATURE[850041119$chain:Probable ATP-dependent RNA helicase DDX56, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117383$short sequence motif:DEAD box, 850117676$short sequence motif:Q motif]
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 12 (CHL1-like helicase homolog, S. cerevisiae),INTERPRO[450002185$IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site, 450005977$IPR006554:Helicase-like, DEXD box c2 type, 450005978$IPR006555:Helicase, ATP-dependent, c2 type, 450009663$IPR010614:DEAD2, 450011687$IPR013020:DNA helicase (DNA repair), Rad3 type, 450012607$IPR014013:Helicase, superfamily 1 and 2, ATP-binding, DinG/Rad3-type]
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 12 (CHL1-like helicase homolog, S. cerevisiae),PIR_SUPERFAMILY[630023581$PIRSF031023:PIRSF031023]
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 12 (CHL1-like helicase homolog, S. cerevisiae),SMART[760000433$SM00488:DEXDc2, 760000435$SM00491:HELICc2]
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 12 (CHL1-like helicase homolog, S. cerevisiae),SP_PIR_KEYWORDS[790000138$atp-binding, 790000258$cell cycle, 790000356$complete proteome, 790000466$dna-binding, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001065$nucleus, 790001339$rna-binding]
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 12 (CHL1-like helicase homolog, S. cerevisiae),UP_SEQ_FEATURE[850041102$chain:Probable ATP-dependent RNA helicase DDX12, 850102507$compositionally biased region:Glu-rich, 850104106$domain:Helicase ATP-binding, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117386$short sequence motif:DEAH]
DENN/MADD domain containing 2C,INTERPRO[450001049$IPR001194:DENN, 450004581$IPR005112:dDENN, 450004582$IPR005113:uDENN]
DENN/MADD domain containing 2C,SMART[760000702$SM00799:DENN, 760000703$SM00800:uDENN, 760000704$SM00801:dDENN]
DENN/MADD domain containing 2C,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
DENN/MADD domain containing 2C,UP_SEQ_FEATURE[850014829$chain:DENN domain-containing protein 2C, 850103503$domain:dDENN, 850103514$domain:DENN, 850105606$domain:uDENN, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
DENN/MADD domain containing 4A,INTERPRO[450001049$IPR001194:DENN, 450002551$IPR002885:Pentatricopeptide repeat, 450004581$IPR005112:dDENN, 450004582$IPR005113:uDENN]
DENN/MADD domain containing 4A,SMART[760000702$SM00799:DENN, 760000703$SM00800:uDENN, 760000704$SM00801:dDENN]
DENN/MADD domain containing 4A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
DENN/MADD domain containing 4A,UP_SEQ_FEATURE[850008638$chain:C-myc promoter-binding protein, 850102572$compositionally biased region:Poly-Glu, 850103503$domain:dDENN, 850103514$domain:DENN, 850105606$domain:uDENN, 850106258$modified residue, 850116806$repeat:PPR 1, 850116817$repeat:PPR 2, 850117294$sequence conflict, 850117295$sequence variant, 850117325$short sequence motif:Bipartite nuclear localization signal]
DENN/MADD domain containing 5B,INTERPRO[450000897$IPR001024:Lipoxygenase, LH2, 450001049$IPR001194:DENN, 450003532$IPR004012:RUN, 450004581$IPR005112:dDENN, 450004582$IPR005113:uDENN]
DENN/MADD domain containing 5B,SMART[760000278$SM00308:LH2, 760000527$SM00593:RUN, 760000702$SM00799:DENN, 760000703$SM00800:uDENN, 760000704$SM00801:dDENN]
DENN/MADD domain containing 5B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane]
DENN/MADD domain containing 5B,UP_SEQ_FEATURE[850014835$chain:DENN domain-containing protein 5B, 850103503$domain:dDENN, 850103514$domain:DENN, 850105029$domain:PLAT, 850105224$domain:RUN 1, 850105225$domain:RUN 2, 850105606$domain:uDENN, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
DIP2 disco-interacting protein 2 homolog B (Drosophila),COG_ONTOLOGY[90000086$Lipid metabolism / Secondary metabolites biosynthesis, transport, and catabolism]
DIP2 disco-interacting protein 2 homolog B (Drosophila),INTERPRO[450000762$IPR000873:AMP-dependent synthetase and ligase, 450009560$IPR010506:DMAP1-binding]
DIP2 disco-interacting protein 2 homolog B (Drosophila),OMIM_DISEASE[520003170$Mental retardation, FRA12A type]
DIP2 disco-interacting protein 2 homolog B (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
DIP2 disco-interacting protein 2 homolog B (Drosophila),UP_SEQ_FEATURE[850015260$chain:Disco-interacting protein 2 homolog B, 850102565$compositionally biased region:Poly-Ala, 850102585$compositionally biased region:Poly-Val, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
DIS3 mitotic control homolog (S. cerevisiae),COG_ONTOLOGY[90000115$Transcription]
DIS3 mitotic control homolog (S. cerevisiae),INTERPRO[450001682$IPR001900:Ribonuclease II and R, 450006016$IPR006596:Nucleotide binding protein, PINc]
DIS3 mitotic control homolog (S. cerevisiae),KEGG_PATHWAY[470038814$hsa03018:RNA degradation]
DIS3 mitotic control homolog (S. cerevisiae),PIR_SUPERFAMILY[630006771$PIRSF006825:mitotic control protein Dis3]
DIS3 mitotic control homolog (S. cerevisiae),SMART[760000582$SM00670:PINc]
DIS3 mitotic control homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000523$exonuclease, 790000526$exosome, 790000743$hydrolase, 790001049$nuclease, 790001065$nucleus, 790001212$polymorphism, 790001339$rna-binding, 790001345$rrna processing]
DIS3 mitotic control homolog (S. cerevisiae),UP_SEQ_FEATURE[850018279$chain:Exosome complex exonuclease RRP44, 850104997$domain:PINc, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
DIS3 mitotic control homolog (S. cerevisiae)-like,INTERPRO[450001682$IPR001900:Ribonuclease II and R]
DIS3 mitotic control homolog (S. cerevisiae)-like,PIR_SUPERFAMILY[630006771$PIRSF006825:mitotic control protein Dis3]
DIS3 mitotic control homolog (S. cerevisiae)-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000523$exonuclease, 790000743$hydrolase, 790001049$nuclease, 790001212$polymorphism, 790001339$rna-binding]
DIS3 mitotic control homolog (S. cerevisiae)-like,UP_SEQ_FEATURE[850015252$chain:DIS3-like exonuclease 1, 850117295$sequence variant, 850118574$splice variant]
DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae),INTERPRO[450010027$IPR011084:DNA repair metallo-beta-lactamase]
DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae),SP_PIR_KEYWORDS[790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae),UP_SEQ_FEATURE[850015509$chain:DNA cross-link repair 1A protein, 850106258$modified residue, 850106259$mutagenesis site, 850113804$region of interest:Nuclear focus formation, 850113808$region of interest:Nuclear localization region, 850117295$sequence variant]
DNA cross-link repair 1B (PSO2 homolog, S. cerevisiae),INTERPRO[450001128$IPR001279:Beta-lactamase-like, 450010027$IPR011084:DNA repair metallo-beta-lactamase]
DNA cross-link repair 1B (PSO2 homolog, S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
DNA cross-link repair 1B (PSO2 homolog, S. cerevisiae),UP_SEQ_FEATURE[850015510$chain:DNA cross-link repair 1B protein, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),BIOCARTA[30000048$h_caspasePathway:Caspase Cascade in Apoptosis, 30000082$h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors , 30000084$h_DNAfragmentPathway:Apoptotic DNA fragmentation and tissue homeostasis, 30000110$h_fasPathway:FAS signaling pathway ( CD95 ), 30000139$h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF, 30000188$h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling, 30000268$h_setPathway:Granzyme A mediated Apoptosis Pathway, 30000297$h_tnfr1Pathway:TNFR1 Signaling Pathway]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),INTERPRO[450003076$IPR003508:Caspase-activated nuclease CIDE-N, 450013753$IPR015311:Apoptosis, DNA fragmentation factor 40 kDa]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),KEGG_PATHWAY[470038843$hsa04210:Apoptosis]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),SMART[760000238$SM00266:CAD]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001049$nuclease, 790001065$nucleus, 790001212$polymorphism]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),UP_SEQ_FEATURE[850015551$chain:DNA fragmentation factor subunit beta, 850103367$domain:CIDE-N, 850105852$helix, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
DNA-damage-inducible transcript 3,BIOCARTA[30000215$h_p38mapkPathway:p38 MAPK Signaling Pathway ]
DNA-damage-inducible transcript 3,INTERPRO[450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010528$IPR011700:Basic leucine zipper, 450014991$IPR016670:DNA damage-inducible transcript 3]
DNA-damage-inducible transcript 3,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway]
DNA-damage-inducible transcript 3,OMIM_DISEASE[520003538$Myxoid liposarcoma]
DNA-damage-inducible transcript 3,PIR_SUPERFAMILY[630013356$PIRSF016571:C/EBPzeta_CHOP_DDIT3]
DNA-damage-inducible transcript 3,SMART[760000306$SM00338:BRLZ]
DNA-damage-inducible transcript 3,SP_PIR_KEYWORDS[790000258$cell cycle, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000466$dna-binding, 790000631$growth arrest, 790001065$nucleus, 790001212$polymorphism, 790001271$Proto-oncogene, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
DNA-damage-inducible transcript 3,UP_SEQ_FEATURE[850015529$chain:DNA damage-inducible transcript 3, 850102572$compositionally biased region:Poly-Glu, 850104712$domain:Leucine-zipper, 850117294$sequence conflict, 850117295$sequence variant]
DPH2 homolog (S. cerevisiae),INTERPRO[450002419$IPR002728:Diphthamide synthesis, DPH1/DHP2, 450009098$IPR010014:Diphthamide synthesis, DHP2]
DPH2 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein]
DPH2 homolog (S. cerevisiae),UP_SEQ_FEATURE[850015237$chain:Diphthamide biosynthesis protein 2, 850106258$modified residue, 850117294$sequence conflict]
DnaJ (Hsp40) homolog, subfamily C, member 16,INTERPRO[450001438$IPR001623:Heat shock protein DnaJ, N-terminal, 450002720$IPR003095:Heat shock protein DnaJ, 450011036$IPR012335:Thioredoxin fold, 450014048$IPR015609:Molecular chaperone, heat shock protein, Hsp40, DnaJ, 450016249$IPR017936:Thioredoxin-like, 450016538$IPR018253:Heat shock protein DnaJ, conserved site]
DnaJ (Hsp40) homolog, subfamily C, member 16,SMART[760000243$SM00271:DnaJ]
DnaJ (Hsp40) homolog, subfamily C, member 16,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
DnaJ (Hsp40) homolog, subfamily C, member 16,UP_SEQ_FEATURE[850016166$chain:DnaJ homolog subfamily C member 16, 850102570$compositionally biased region:Poly-Gln, 850102572$compositionally biased region:Poly-Glu, 850104487$domain:J, 850105478$domain:Thioredoxin, 850105770$glycosylation site:N-linked (GlcNAc...), 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
E74-like factor 4 (ets domain transcription factor),INTERPRO[450000358$IPR000418:Ets, 450010816$IPR011991:Winged helix repressor DNA-binding]
E74-like factor 4 (ets domain transcription factor),SMART[760000360$SM00413:ETS]
E74-like factor 4 (ets domain transcription factor),SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
E74-like factor 4 (ets domain transcription factor),UP_SEQ_FEATURE[850018052$chain:ETS-related transcription factor Elf-4, 850102913$DNA-binding region:ETS, 850106258$modified residue, 850114563$region of interest:RUNX1-binding, 850117294$sequence conflict]
EF-hand calcium binding domain 2,INTERPRO[450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016534$IPR018249:EF-HAND 2]
EF-hand calcium binding domain 2,SMART[760000046$SM00054:EFh]
EF-hand calcium binding domain 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001304$repeat]
EF-hand calcium binding domain 2,UP_SEQ_FEATURE[850016943$chain:EF-hand calcium-binding domain-containing protein 2, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850117294$sequence conflict, 850118574$splice variant]
EF-hand calcium binding domain 4A,INTERPRO[450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450014509$IPR016160:Aldehyde dehydrogenase, conserved site, 450016534$IPR018249:EF-HAND 2]
EF-hand calcium binding domain 4A,SMART[760000046$SM00054:EFh]
EF-hand calcium binding domain 4A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
EF-hand calcium binding domain 4A,UP_SEQ_FEATURE[850016945$chain:EF-hand calcium-binding domain-containing protein 4A, 850102404$compositionally biased region:Arg-rich, 850102507$compositionally biased region:Glu-rich, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850117295$sequence variant, 850118574$splice variant]
EGF, latrophilin and seven transmembrane domain containing 1,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000174$IPR000203:GPS, 450000637$IPR000742:EGF-like, type 3, 450000724$IPR000832:GPCR, family 2, secretin-like, 450001663$IPR001881:EGF-like calcium-binding, 450005636$IPR006210:EGF-like, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450016289$IPR017981:GPCR, family 2-like, 450016291$IPR017983:GPCR, family 2, secretin-like, conserved site, 450016397$IPR018097:EGF-like calcium-binding, conserved site, 450016532$IPR018247:EF-HAND 1]
EGF, latrophilin and seven transmembrane domain containing 1,SMART[760000153$SM00179:EGF_CA, 760000155$SM00181:EGF, 760000273$SM00303:GPS]
EGF, latrophilin and seven transmembrane domain containing 1,SP_PIR_KEYWORDS[790000211$calcium, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000481$egf-like domain, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001546$transducer, 790001555$transmembrane]
EGF, latrophilin and seven transmembrane domain containing 1,UP_SEQ_FEATURE[850016985$chain:EGF, latrophilin and seven transmembrane domain-containing protein 1, 850102572$compositionally biased region:Poly-Glu, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103644$domain:EGF-like 2; calcium-binding, 850104076$domain:GPS, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850117969$site:Cleavage, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
EPH receptor A8,INTERPRO[450000618$IPR000719:Protein kinase, core, 450000955$IPR001090:Ephrin receptor, ligand binding, 450001096$IPR001245:Tyrosine protein kinase, 450001270$IPR001426:Receptor tyrosine kinase, class V, conserved site, 450001470$IPR001660:Sterile alpha motif SAM, 450003484$IPR003961:Fibronectin, type III, 450003485$IPR003962:Fibronectin, type III subdomain, 450007559$IPR008266:Tyrosine protein kinase, active site, 450008173$IPR008957:Fibronectin, type III-like fold, 450011699$IPR013032:EGF-like region, conserved site, 450012380$IPR013761:Sterile alpha motif-type, 450014581$IPR016257:Tyrosine-protein kinase, ephrin receptor, 450015769$IPR017441:Protein kinase, ATP binding site]
EPH receptor A8,KEGG_PATHWAY[470038851$hsa04360:Axon guidance]
EPH receptor A8,PIR_SUPERFAMILY[630000780$PIRSF000666:TyrPK_ephrin_receptor]
EPH receptor A8,SMART[760000051$SM00060:FN3, 760000192$SM00219:TyrKc, 760000399$SM00454:SAM, 760000544$SM00615:EPH_lbd]
EPH receptor A8,SP_PIR_KEYWORDS[790000002$3d-structure, 790000138$atp-binding, 790000356$complete proteome, 790000616$glycoprotein, 790000825$kinase, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001547$transferase, 790001555$transmembrane, 790001586$tyrosine-protein kinase]
EPH receptor A8,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850017618$chain:Ephrin type-A receptor 8, 850102480$compositionally biased region:Cys-rich, 850103800$domain:Fibronectin type-III 1, 850103849$domain:Fibronectin type-III 2, 850105086$domain:Protein kinase, 850105249$domain:SAM, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117634$short sequence motif:PDZ-binding, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ER degradation enhancer, mannosidase alpha-like 2,INTERPRO[450001227$IPR001382:Glycoside hydrolase, family 47]
ER degradation enhancer, mannosidase alpha-like 2,PIR_SUPERFAMILY[630014256$PIRSF017531:mannosyl-oligosaccharide 1,2-alpha-mannosidase, 1A type]
ER degradation enhancer, mannosidase alpha-like 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790001212$polymorphism, 790001363$Secreted, 790001405$signal, 790001595$unfolded protein response]
ER degradation enhancer, mannosidase alpha-like 2,UP_SEQ_FEATURE[850017746$chain:ER degradation-enhancing alpha- mannosidase-like 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
F-box and leucine-rich repeat protein 13,COG_ONTOLOGY[90000112$Signal transduction mechanisms / RNA processing and modification]
F-box and leucine-rich repeat protein 13,INTERPRO[450001603$IPR001810:Cyclin-like F-box, 450005976$IPR006553:Leucine-rich repeat, cysteine-containing subtype]
F-box and leucine-rich repeat protein 13,PIR_SUPERFAMILY[630028327$PIRSF036848:conserved protein with F-box/LRR-repeat, Skp2 type]
F-box and leucine-rich repeat protein 13,SMART[760000228$SM00256:FBOX, 760000331$SM00367:LRR_CC]
F-box and leucine-rich repeat protein 13,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000853$leucine-rich repeat, 790001212$polymorphism, 790001304$repeat, 790001593$ubl conjugation pathway]
F-box and leucine-rich repeat protein 13,UP_SEQ_FEATURE[850018787$chain:F-box/LRR-repeat protein 13, 850103725$domain:F-box, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
F-box protein 9,INTERPRO[450001603$IPR001810:Cyclin-like F-box]
F-box protein 9,SMART[760000228$SM00256:FBOX]
F-box protein 9,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001537$tpr repeat, 790001593$ubl conjugation pathway]
F-box protein 9,UP_SEQ_FEATURE[850018511$chain:F-box only protein 9, 850103725$domain:F-box, 850117118$repeat:TPR, 850118574$splice variant]
FCF1 small subunit (SSU) processome component homolog (S. cerevisiae),INTERPRO[450006016$IPR006596:Nucleotide binding protein, PINc, 450006381$IPR006984:Protein of unknown function DUF652]
FCF1 small subunit (SSU) processome component homolog (S. cerevisiae),PIR_SUPERFAMILY[630014351$PIRSF017667:exonuclease with PIN domain, eukaryotic YDR339c type]
FCF1 small subunit (SSU) processome component homolog (S. cerevisiae),SMART[760000582$SM00670:PINc]
FCF1 small subunit (SSU) processome component homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790001065$nucleus, 790001331$ribosome biogenesis, 790001345$rrna processing]
FCF1 small subunit (SSU) processome component homolog (S. cerevisiae),UP_SEQ_FEATURE[850058644$chain:rRNA-processing protein FCF1 homolog, 850104997$domain:PINc]
FERM domain containing 6,INTERPRO[450000257$IPR000299:FERM domain, 450010818$IPR011993:Pleckstrin homology-type, 450012944$IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle, 450017249$IPR018979:FERM, N-terminal, 450017250$IPR018980:FERM, C-terminal PH-like domain, 450017984$IPR019747:FERM conserved site, 450017985$IPR019748:FERM central domain, 450017986$IPR019749:Band 4.1 domain]
FERM domain containing 6,SMART[760000266$SM00295:B41]
FERM domain containing 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001162$phosphoprotein]
FERM domain containing 6,UP_SEQ_FEATURE[850019182$chain:FERM domain-containing protein 6, 850102581$compositionally biased region:Poly-Ser, 850102584$compositionally biased region:Poly-Tyr, 850103760$domain:FERM, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
FGFR1 oncogene partner 2,INTERPRO[450007825$IPR008555:Protein of unknown function DUF837]
FGFR1 oncogene partner 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm]
FGFR1 oncogene partner 2,UP_SEQ_FEATURE[850019347$chain:FGFR1 oncogene partner 2, 850106258$modified residue, 850117294$sequence conflict, 850117881$site:Breakpoint for translocation to form FGFR1OP2-FGFR1, 850118574$splice variant]
FIG4 homolog (S. cerevisiae),INTERPRO[450001784$IPR002013:Synaptojanin, N-terminal]
FIG4 homolog (S. cerevisiae),OMIM_DISEASE[520000280$Amyotrophic lateral sclerosis 11, 520000969$Charcot-Marie-Tooth disease, type 4J]
FIG4 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000080$amyotrophic lateral sclerosis, 790000289$charcot-marie-tooth disease, 790000356$complete proteome, 790000446$disease mutation, 790000501$endosome, 790000743$hydrolase, 790000919$membrane, 790001015$neurodegeneration, 790001020$neuropathy, 790001212$polymorphism]
FIG4 homolog (S. cerevisiae),UP_SEQ_FEATURE[850039945$chain:Polyphosphoinositide phosphatase, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850105248$domain:SAC, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant]
FK506 binding protein 2, 13kDa,INTERPRO[450001034$IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type]
FK506 binding protein 2, 13kDa,PIR_SUPERFAMILY[630001631$PIRSF001468:FK506-binding protein 1]
FK506 binding protein 2, 13kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000810$Isomerase, 790000919$membrane, 790001212$polymorphism, 790001343$Rotamase, 790001405$signal]
FK506 binding protein 2, 13kDa,UP_SEQ_FEATURE[850019525$chain:FK506-binding protein 2, 850105058$domain:PPIase FKBP-type, 850105852$helix, 850117295$sequence variant, 850117653$short sequence motif:Prevents secretion from ER, 850117814$signal peptide, 850118575$strand, 850118624$turn]
FK506 binding protein 4, 59kDa,INTERPRO[450001034$IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type, 450001282$IPR001440:Tetratricopeptide TPR-1, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450017972$IPR019734:Tetratricopeptide repeat]
FK506 binding protein 4, 59kDa,SMART[760000020$SM00028:TPR]
FK506 binding protein 4, 59kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000394$cyclosporin A binding, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000810$Isomerase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001343$Rotamase, 790001537$tpr repeat]
FK506 binding protein 4, 59kDa,UP_SEQ_FEATURE[850019530$chain:FK506-binding protein 4, 850019531$chain:FK506-binding protein 4, N-terminally processed, 850105059$domain:PPIase FKBP-type 1, 850105060$domain:PPIase FKBP-type 2, 850105852$helix, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117295$sequence variant, 850118575$strand, 850118624$turn]
FXYD domain containing ion transport regulator 2,BIOCARTA[30000023$h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2]
FXYD domain containing ion transport regulator 2,INTERPRO[450000237$IPR000272:Ion-transport regulator, FXYD region]
FXYD domain containing ion transport regulator 2,KEGG_PATHWAY[470038844$hsa04260:Cardiac muscle contraction]
FXYD domain containing ion transport regulator 2,OMIM_DISEASE[520002525$Hypomagnesemia-2, renal]
FXYD domain containing ion transport regulator 2,PIR_SUPERFAMILY[630021015$PIRSF027828:PIRSF027828]
FXYD domain containing ion transport regulator 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000798$ion transport, 790000919$membrane, 790001226$potassium, 790001229$potassium transport, 790001240$primary hypomagnesemia, 790001418$Sodium, 790001421$Sodium transport, 790001422$sodium/potassium transport, 790001555$transmembrane, 790001558$transport]
FXYD domain containing ion transport regulator 2,UP_SEQ_FEATURE[850061295$chain:Sodium/potassium-transporting ATPase subunit gamma, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
FYN binding protein (FYB-120/130),INTERPRO[450001294$IPR001452:Src homology-3 domain, 450010373$IPR011511:Variant SH3, 450016415$IPR018115:Xylose isomerase, active site]
FYN binding protein (FYB-120/130),SMART[760000295$SM00326:SH3]
FYN binding protein (FYB-120/130),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain]
FYN binding protein (FYB-120/130),UP_SEQ_FEATURE[850020201$chain:FYN-binding protein, 850102580$compositionally biased region:Poly-Pro, 850105350$domain:SH3, 850105852$helix, 850106258$modified residue, 850112832$region of interest:Interaction with SKAP1, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850117706$short sequence motif:SH2-binding, 850117709$short sequence motif:SH2-binding; to FYN, 850117710$short sequence motif:SH2-binding; to LCP2, 850118575$strand, 850118624$turn]
Fas apoptotic inhibitory molecule 2,INTERPRO[450005640$IPR006214:Uncharacterised protein family UPF0005]
Fas apoptotic inhibitory molecule 2,OMIM_DISEASE[520002058$Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity]
Fas apoptotic inhibitory molecule 2,SP_PIR_KEYWORDS[790000109$Apoptosis, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001223$postsynaptic cell membrane, 790001475$synapse, 790001555$transmembrane]
Fas apoptotic inhibitory molecule 2,UP_SEQ_FEATURE[850018981$chain:Fas apoptotic inhibitory molecule 2, 850102581$compositionally biased region:Poly-Ser, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850118623$transmembrane region]
Fas apoptotic inhibitory molecule 3,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
Fas apoptotic inhibitory molecule 3,SMART[760000357$SM00409:IG]
Fas apoptotic inhibitory molecule 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000763$immune response, 790000768$Immunoglobulin domain, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
Fas apoptotic inhibitory molecule 3,UP_SEQ_FEATURE[850018982$chain:Fas apoptotic inhibitory molecule 3, 850102404$compositionally biased region:Arg-rich, 850102883$disulfide bond, 850104199$domain:Ig-like, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),BBID[10000076$56.Macrophage_regulation_of_CD4+T_cells]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),KEGG_PATHWAY[470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038916$hsa05322:Systemic lupus erythematosus]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),OMIM_DISEASE[520002972$Lupus erythematosus, systemic, susceptibility, 520003622$Neutropenia, alloimmune neonatal, 520005034$Viral infections, recurrent]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),PIR_SUPERFAMILY[630002118$PIRSF001980:Fc gamma receptor III]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),SMART[760000357$SM00409:IG]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000761$igg-binding protein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),UP_SEQ_FEATURE[850029060$chain:Low affinity immunoglobulin gamma Fc region receptor III-A, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
Fc receptor-like 2,INTERPRO[450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
Fc receptor-like 2,SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG]
Fc receptor-like 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
Fc receptor-like 2,UP_SEQ_FEATURE[850019114$chain:Fc receptor-like protein 2, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104389$domain:Ig-like C2-type 4, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117520$short sequence motif:ITIM motif 1, 850117521$short sequence motif:ITIM motif 2, 850117522$short sequence motif:ITIM motif 3, 850117523$short sequence motif:ITIM motif 4, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
Fc receptor-like 5,INTERPRO[450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
Fc receptor-like 5,SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG]
Fc receptor-like 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
Fc receptor-like 5,UP_SEQ_FEATURE[850019117$chain:Fc receptor-like protein 5, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104389$domain:Ig-like C2-type 4, 850104400$domain:Ig-like C2-type 5, 850104402$domain:Ig-like C2-type 6, 850104403$domain:Ig-like C2-type 7, 850104404$domain:Ig-like C2-type 8, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117520$short sequence motif:ITIM motif 1, 850117521$short sequence motif:ITIM motif 2, 850117522$short sequence motif:ITIM motif 3, 850117523$short sequence motif:ITIM motif 4, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 61,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
G protein-coupled receptor 61,PIR_SUPERFAMILY[630030082$PIRSF038578:probable G protein-coupled receptor 61, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
G protein-coupled receptor 61,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
G protein-coupled receptor 61,UP_SEQ_FEATURE[850042074$chain:Probable G-protein coupled receptor 61, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 68,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450004847$IPR005389:OGR1 sphingosylphosphorylcholine receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
G protein-coupled receptor 68,PIR_SUPERFAMILY[630005778$PIRSF005853:GPR4-like G protein-coupled receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
G protein-coupled receptor 68,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001580$tumor suppressor]
G protein-coupled receptor 68,UP_SEQ_FEATURE[850036439$chain:Ovarian cancer G-protein coupled receptor 1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 77,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450001124$IPR001274:C5A-anaphylatoxin receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
G protein-coupled receptor 77,PIR_SUPERFAMILY[630030070$PIRSF038566:C5a anaphylatoxin chemotactic receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
G protein-coupled receptor 77,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
G protein-coupled receptor 77,UP_SEQ_FEATURE[850008821$chain:C5a anaphylatoxin chemotactic receptor C5L2, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 89C; G protein-coupled receptor 89B; G protein-coupled receptor 89A,INTERPRO[450014108$IPR015672:G-protein coupled receptor 89-related]
G protein-coupled receptor 89C; G protein-coupled receptor 89B; G protein-coupled receptor 89A,PIR_SUPERFAMILY[630011150$PIRSF013287:uncharacterized conserved protein]
G protein-coupled receptor 89C; G protein-coupled receptor 89B; G protein-coupled receptor 89A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001555$transmembrane]
G protein-coupled receptor 89C; G protein-coupled receptor 89B; G protein-coupled receptor 89A,UP_SEQ_FEATURE[850046312$chain:Protein GPR89, 850053876$chain:Putative protein GPR89C, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
GA binding protein transcription factor, beta subunit 1,INTERPRO[450001870$IPR002110:Ankyrin]
GA binding protein transcription factor, beta subunit 1,PIR_SUPERFAMILY[630027779$PIRSF036345:nuclear respiratory factor-2 beta-1 chain]
GA binding protein transcription factor, beta subunit 1,SMART[760000220$SM00248:ANK]
GA binding protein transcription factor, beta subunit 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790000445$direct protein sequencing, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation]
GA binding protein transcription factor, beta subunit 1,UP_SEQ_FEATURE[850020362$chain:GA-binding protein subunit beta-1, 850106259$mutagenesis site, 850114911$region of interest:Transcription activation and HCFC1 interaction, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
GATA binding protein 3,BBID[10000099$78.B_Cell_Development, 10000102$80.T_cell_Activation, 10000111$89.CD4_T_Cell_Differentiation]
GATA binding protein 3,BIOCARTA[30000123$h_GATA3pathway:GATA3 participate in activating the Th2 cytokine genes expression]
GATA binding protein 3,INTERPRO[450000580$IPR000679:Zinc finger, GATA-type, 450011732$IPR013088:Zinc finger, NHR/GATA-type, 450014695$IPR016374:Transcription factor, GATA-1/2/3]
GATA binding protein 3,OMIM_DISEASE[520002530$Hypoparathyroidism, sensorineural deafness, and renal dysplasia]
GATA binding protein 3,PIR_SUPERFAMILY[630003115$PIRSF003027:TF_GATA-1/2/3]
GATA binding protein 3,SMART[760000352$SM00401:ZnF_GATA]
GATA binding protein 3,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000415$deafness, 790000446$disease mutation, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
GATA binding protein 3,UP_SEQ_FEATURE[850064903$chain:Trans-acting T-cell-specific transcription factor GATA-3, 850102581$compositionally biased region:Poly-Ser, 850102582$compositionally biased region:Poly-Thr, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118823$zinc finger region:GATA-type 1, 850118824$zinc finger region:GATA-type 2]
GDP dissociation inhibitor 2,INTERPRO[450000699$IPR000806:Rab GDI protein, 450001776$IPR002005:Rab GTPase activator, 450016490$IPR018203:GDP dissociation inhibitor]
GDP dissociation inhibitor 2,PIR_SUPERFAMILY[630016226$PIRSF019647:GDP dissociation inhibitor XAP-4]
GDP dissociation inhibitor 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000640$GTPase activation, 790000919$membrane, 790001162$phosphoprotein]
GDP dissociation inhibitor 2,UP_SEQ_FEATURE[850056509$chain:Rab GDP dissociation inhibitor beta, 850106258$modified residue, 850117294$sequence conflict]
GRB2-associated binding protein 2,INTERPRO[450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type]
GRB2-associated binding protein 2,KEGG_PATHWAY[470038871$hsa04664:Fc epsilon RI signaling pathway, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038910$hsa05220:Chronic myeloid leukemia]
GRB2-associated binding protein 2,OMIM_DISEASE[520001954$GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers]
GRB2-associated binding protein 2,SMART[760000205$SM00233:PH]
GRB2-associated binding protein 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
GRB2-associated binding protein 2,UP_SEQ_FEATURE[850022390$chain:GRB2-associated-binding protein 2, 850104979$domain:PH, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850117711$short sequence motif:SH3-binding, 850118574$splice variant]
GTP cyclohydrolase I feedback regulator,INTERPRO[450008232$IPR009112:GTP cyclohydrolase I, feedback regulatory protein]
GTP cyclohydrolase I feedback regulator,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000743$hydrolase, 790000919$membrane, 790001065$nucleus]
GTP cyclohydrolase I feedback regulator,UP_SEQ_FEATURE[850022514$chain:GTP cyclohydrolase 1 feedback regulatory protein]
